A Trial of Skin Care Protocols for Facial Resurfacing

The Plastic Surgery Foundation

Overview

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Study Type

INTERVENTIONAL

Conditions

Facial Photo Damage Periocular Fine Wrinkles Perioral Fine Wrinkles

Interventions

Obagi New-Derm SystemOTHER

Standard of CareOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser. * Fitzpatrick I-IV skin types Exclusion Criteria: * patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.

Locations (9)

Suite 135

Oxnard, California, United States

Suite 175

Rancho Santa Margarita, California, United States

Aesthetic and Plastic Surgery Institute

Greeley, Colorado, United States

Brevard Plastic Surgery and Skin Institute

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.